Cargando…

Diffusion imaging in Huntington’s disease: comprehensive review

Huntington’s disease (HD) is a monogenic disorder with 100% penetrance. With the advent of genetic testing in adults, disease-related, structural brain changes can be investigated from the earliest, premorbid stages of HD. While examining macrostructural change characterises global neuronal damage,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Estevez-Fraga, Carlos, Scahill, Rachael, Rees, Geraint, Tabrizi, Sarah J, Gregory, Sarah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Movement Disorders
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803908/ https://www.ncbi.nlm.nih.gov/pubmed/33033167 http://dx.doi.org/10.1136/jnnp-2020-324377

Ejemplares similares

The differential diagnosis of Huntington's disease-like syndromes: ‘red flags’ for the clinician
por: Martino, Davide, et al.
Publicado: (2013)

Fetal striatal grafting slows motor and cognitive decline of Huntington's disease
por: Paganini, Marco, et al.
Publicado: (2014)

Natural history and burden of Huntington's disease in the UK: A population‐based cohort study
por: Furby, Hannah, et al.
Publicado: (2022)

The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease
por: Barker, Roger A, et al.
Publicado: (2013)

Clinical and genetic characteristics of late‐onset Huntington's disease in a large European cohort
por: Petracca, Martina, et al.
Publicado: (2022)

Systematic review of data‐driven cognitive subtypes in Parkinson disease
por: Pourzinal, Dana, et al.
Publicado: (2022)

A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
por: Lo, Christine, et al.
Publicado: (2022)

Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review
por: Otani, Rafael Tomio Vicentini, et al.
Publicado: (2022)

Structural magnetic resonance imaging in dystonia: A systematic review of methodological approaches and findings
por: MacIver, Claire L., et al.
Publicado: (2022)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

Predictors of malnutrition risk in neurodegenerative diseases: The role of swallowing function
por: Pizzorni, Nicole, et al.
Publicado: (2022)

Dynamics of Cortical Degeneration Over a Decade in Huntington’s Disease
por: Johnson, Eileanoir B., et al.
Publicado: (2021)

Intellectual enrichment and genetic modifiers of cognition and brain volume in Huntington’s disease
por: Papoutsi, Marina, et al.
Publicado: (2022)

How I treat Parkinson's disease
por: Barbosa, Egberto Reis, et al.
Publicado: (2022)

Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review
por: Akbar, Umer, et al.
Publicado: (2021)

Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2022)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
por: Sauerbier, Anna, et al.
Publicado: (2021)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Functional connectivity and topology in patients with restless legs syndrome: a case–control resting‐state functional magnetic resonance imaging study
por: Tuovinen, N., et al.
Publicado: (2020)

Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?
por: Doherty, Karen M, et al.
Publicado: (2013)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

The prediagnostic phase of Parkinson's disease
por: Noyce, Alastair John, et al.
Publicado: (2016)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

Progressive alterations in white matter microstructure across the timecourse of Huntington's disease
por: Estevez‐Fraga, Carlos, et al.
Publicado: (2023)

Management of rare movement disorders in Europe: outcome of surveys of the European Reference Network for Rare Neurological Diseases
por: Painous, C., et al.
Publicado: (2020)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Clinical implications of early caudate dysfunction in Parkinson’s disease
por: Pasquini, Jacopo, et al.
Publicado: (2019)

Differences in globus pallidus neuronal firing rates and patterns relate to different disease biology in children with dystonia
por: McClelland, V M, et al.
Publicado: (2016)

Bilateral adaptive deep brain stimulation is effective in Parkinson's disease
por: Little, Simon, et al.
Publicado: (2016)

Brain iron deposition is linked with cognitive severity in Parkinson’s disease
por: Thomas, George Edward Calver, et al.
Publicado: (2020)

Validation of new diagnostic criteria for fatigue in patients with Parkinson disease
por: Siciliano, Mattia, et al.
Publicado: (2022)

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study
por: Kazmi, Hiba, et al.
Publicado: (2021)

Multicentre, randomised controlled trial of PDSAFE, a physiotherapist-delivered fall prevention programme for people with Parkinson’s
por: Chivers Seymour, Kim, et al.
Publicado: (2019)

Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_b0ft83nvfve6e9uni9akbpc084